Download PDF
Clin Colon Rectal Surg 2010; 23(4): 274-284
DOI: 10.1055/s-0030-1268254
© Thieme Medical Publishers

Management of Acute Colitis and Toxic Megacolon

Scott A. Strong1
  • 1Department of Colorectal Surgery, Cleveland Clinic, Cleveland, Ohio
Further Information

Publication History

Publication Date:
07 December 2010 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Severe colitis is a well-defined condition that can develop in patients afflicted with ulcerative colitis, but typically responds to a variety of medical therapies. Operative intervention is warranted when massive hemorrhage, perforation, or peritonitis complicates the clinical scenario or medical therapy fails to control the disease. Of the operative options, total/subtotal colectomy and end ileostomy is the usual procedure of choice especially if the operation can be performed through a laparoscopic approach.

KEYWORDS

Ulcerative colitis - toxic colitis - acute colitis - total colectomy - ileostomy

REFERENCES

  • 1 Silverberg M S, Satsangi J, Ahmad T et al.. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.  Can J Gastroenterol. 2005;  19(Suppl A) 5-36
    PubMedGoogle Scholar
  • 2 Brown S R, Haboubi N, Hampton J, George B, Travis S PL. ACPGBI . The management of acute severe colitis: ACPGBI position statement.  Colorectal Dis. 2008;  10(Suppl 3) 8-29
    CrossrefPubMedGoogle Scholar
  • 3 Kornbluth A, Sachar D B. Practice Parameters Committee of the American College of Gastroenterology . Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee.  Am J Gastroenterol. 2010;  105(3) 501-523, quiz 524
    CrossrefPubMedGoogle Scholar
  • 4 Travis S PL, Stange E F, Lémann M et al.. Gassull M for the European Crohn's and Colitis Organisation (ECCO). European evidence-based consensus on the management of ulcerative colitis: current management.  J Crohn's Colitis. 2008;  2 24-62
    PubMedGoogle Scholar
  • 5 Truelove S C, Witts L J. Cortisone in ulcerative colitis; final report on a therapeutic trial.  BMJ. 1955;  2(4947) 1041-1048
    CrossrefPubMedGoogle Scholar
  • 6 Hanauer S B. Inflammatory bowel disease.  N Engl J Med. 1996;  334(13) 841-848
    CrossrefPubMedGoogle Scholar
  • 7 Marshak R H, Lester L J. Megacolon a complication of ulcerative colitis.  Gastroenterology. 1950;  16(4) 768-772
    PubMedGoogle Scholar
  • 8 Gan S I, Beck P L. A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management.  Am J Gastroenterol. 2003;  98(11) 2363-2371
    CrossrefPubMedGoogle Scholar
  • 9 Sheth S G, LaMont J T. Toxic megacolon.  Lancet. 1998;  351(9101) 509-513
    CrossrefPubMedGoogle Scholar
  • 10 Jones J H, Chapman M. Definition of megacolon in colitis.  Gut. 1969;  10(7) 562-564
    CrossrefPubMedGoogle Scholar
  • 11 Benazzato L, D'Incà R, Grigoletto F et al.. Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment.  Dig Liver Dis. 2004;  36(7) 461-466
    CrossrefPubMedGoogle Scholar
  • 12 Travis S P, Farrant J M, Ricketts C et al.. Predicting outcome in severe ulcerative colitis.  Gut. 1996;  38(6) 905-910
    CrossrefPubMedGoogle Scholar
  • 13 Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M. An index of disease activity in patients with ulcerative colitis.  Am J Gastroenterol. 1992;  87(8) 971-976
    PubMedGoogle Scholar
  • 14 Lindgren S C, Flood L M, Kilander A F, Löfberg R, Persson T B, Sjödahl R I. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis.  Eur J Gastroenterol Hepatol. 1998;  10(10) 831-835
    CrossrefPubMedGoogle Scholar
  • 15 Ho G T, Mowat C, Goddard C J et al.. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery.  Aliment Pharmacol Ther. 2004;  19(10) 1079-1087
    CrossrefPubMedGoogle Scholar
  • 16 Carbonnel F, Gargouri D, Lémann M et al.. Predictive factors of outcome of intensive intravenous treatment for attacks of ulcerative colitis.  Aliment Pharmacol Ther. 2000;  14(3) 273-279
    CrossrefPubMedGoogle Scholar
  • 17 Criscuoli V, Casà A, Orlando A et al.. Severe acute colitis associated with CMV: a prevalence study.  Dig Liver Dis. 2004;  36(12) 818-820
    CrossrefPubMedGoogle Scholar
  • 18 Chew C N, Nolan D J, Jewell D P. Small bowel gas in severe ulcerative colitis.  Gut. 1991;  32(12) 1535-1537
    CrossrefPubMedGoogle Scholar
  • 19 Turner D, Walsh C M, Steinhart A H, Griffiths A M. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression.  Clin Gastroenterol Hepatol. 2007;  5(1) 103-110
    CrossrefPubMedGoogle Scholar
  • 20 Bossa F, Fiorella S, Caruso N et al.. Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial.  Am J Gastroenterol. 2007;  102(3) 601-608
    CrossrefPubMedGoogle Scholar
  • 21 Gustavsson A, Halfvarson J, Magnuson A, Sandberg-Gertzén H, Tysk C, Järnerot G. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era.  Am J Gastroenterol. 2007;  102(11) 2513-2519
    CrossrefPubMedGoogle Scholar
  • 22 Lichtiger S, Present D H, Kornbluth A et al.. Cyclosporine in severe ulcerative colitis refractory to steroid therapy.  N Engl J Med. 1994;  330(26) 1841-1845
    CrossrefPubMedGoogle Scholar
  • 23 D'Haens G, Lemmens L, Geboes K et al.. Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.  Gastroenterology. 2001;  120(6) 1323-1329
    CrossrefPubMedGoogle Scholar
  • 24 Van Assche G, D'Haens G, Noman M et al.. Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis.  Gastroenterology. 2003;  125(4) 1025-1031
    CrossrefPubMedGoogle Scholar
  • 25 Durai D, Hawthorne A B. Review article: how and when to use ciclosporin in ulcerative colitis.  Aliment Pharmacol Ther. 2005;  22(10) 907-916
    CrossrefPubMedGoogle Scholar
  • 26 Actis G C, Fadda M, David E, Sapino A. Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study.  BMC Gastroenterol. 2007;  7 13
    CrossrefPubMedGoogle Scholar
  • 27 Campbell S, Travis S, Jewell D. Ciclosporin use in acute ulcerative colitis: a long-term experience.  Eur J Gastroenterol Hepatol. 2005;  17(1) 79-84
    CrossrefPubMedGoogle Scholar
  • 28 Rowe F A, Walker J H, Karp L C, Vasiliauskas E A, Plevy S E, Targan S R. Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis.  Am J Gastroenterol. 2000;  95(8) 2000-2008
    CrossrefPubMedGoogle Scholar
  • 29 Järnerot G, Hertervig E, Friis-Liby I et al.. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.  Gastroenterology. 2005;  128(7) 1805-1811
    CrossrefPubMedGoogle Scholar
  • 30 Sands B E, Tremaine W J, Sandborn W J et al.. Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.  Inflamm Bowel Dis. 2001;  7(2) 83-88
    CrossrefPubMedGoogle Scholar
  • 31 Bressler B, Law J K, Al Nahdi Sheraisher N et al.. The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitis.  Can J Gastroenterol. 2008;  22(11) 937-940
    PubMedGoogle Scholar
  • 32 Lees C W, Heys D, Ho G T Scottish Society of Gastroenterology Infliximab Group et al. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.  Aliment Pharmacol Ther. 2007;  26(3) 411-419
    CrossrefPubMedGoogle Scholar
  • 33 Kohn A, Daperno M, Armuzzi A et al.. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up.  Aliment Pharmacol Ther. 2007;  26(5) 747-756
    CrossrefPubMedGoogle Scholar
  • 34 Maser E A, Deconda D, Lichtiger S, Ullman T, Present D H, Kornbluth A. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.  Clin Gastroenterol Hepatol. 2008;  6(10) 1112-1116
    CrossrefPubMedGoogle Scholar
  • 35 Teeuwen P H, Stommel M W, Bremers A J, van der Wilt G J, de Jong D J, Bleichrodt R P. Colectomy in patients with acute colitis: a systematic review.  J Gastrointest Surg. 2009;  13(4) 676-686
    CrossrefPubMedGoogle Scholar
  • 36 Crile Jr G C, Thomas Jr C Y. The treatment of acute toxic ulcerative colitis by ileostomy and simultaneous colectomy.  Gastroenterology. 1951;  19(1) 58-68
    PubMedGoogle Scholar
  • 37 Turnbull Jr R B, Hawk W A, Weakley F L. Surgical treatment of toxic megacolon. Ileostomy and colostomy to prepare patients for colectomy.  Am J Surg. 1971;  122(3) 325-331
    CrossrefPubMedGoogle Scholar
  • 38 Ooi B S, Remzi F H, Fazio V W. Turnbull-Blowhole colostomy for toxic ulcerative colitis in pregnancy: report of two cases.  Dis Colon Rectum. 2003;  46(1) 111-115
    CrossrefPubMedGoogle Scholar
  • 39 Remzi F H, Oncel M, Hull T L, Strong S A, Lavery I C, Fazio V W. Current indications for blow-hole colostomy:ileostomy procedure. A single center experience.  Int J Colorectal Dis. 2003;  18(4) 361-364
    PubMedGoogle Scholar
  • 40 Dinnewitzer A J, Wexner S D, Baig M K et al.. Timing of restorative proctectomy following subtotal colectomy in patients with inflammatory bowel disease.  Colorectal Dis. 2006;  8(4) 278-282
    CrossrefPubMedGoogle Scholar
  • 41 Ambroze Jr W L, Wolff B G, Kelly K A, Beart Jr R W, Dozois R R, Ilstrup D M. Let sleeping dogs lie: role of the omentum in the ileal pouch-anal anastomosis procedure.  Dis Colon Rectum. 1991;  34(7) 563-565
    CrossrefPubMedGoogle Scholar
  • 42 Carter F M, McLeod R S, Cohen Z. Subtotal colectomy for ulcerative colitis: complications related to the rectal remnant.  Dis Colon Rectum. 1991;  34(11) 1005-1009
    CrossrefPubMedGoogle Scholar
  • 43 McKee R F, Keenan R A, Munro A. Colectomy for acute colitis: is it safe to close the rectal stump?.  Int J Colorectal Dis. 1995;  10(4) 222-224
    CrossrefPubMedGoogle Scholar
  • 44 Trickett J P, Tilney H S, Gudgeon A M, Mellor S G, Edwards D P. Management of the rectal stump after emergency sub-total colectomy: which surgical option is associated with the lowest morbidity?.  Colorectal Dis. 2005;  7(5) 519-522
    CrossrefPubMedGoogle Scholar
  • 45 Karch L A, Bauer J J, Gorfine S R, Gelernt I M. Subtotal colectomy with Hartmann's pouch for inflammatory bowel disease.  Dis Colon Rectum. 1995;  38(6) 635-639
    CrossrefPubMedGoogle Scholar
  • 46 Ouaïssi M, Lefevre J H, Bretagnol F, Alves A, Valleur P, Panis Y. Laparoscopic 3-step restorative proctocolectomy: comparative study with open approach in 45 patients.  Surg Laparosc Endosc Percutan Tech. 2008;  18(4) 357-362
    CrossrefPubMedGoogle Scholar
  • 47 Chung T P, Fleshman J W, Birnbaum E H et al.. Laparoscopic vs. open total abdominal colectomy for severe colitis: impact on recovery and subsequent completion restorative proctectomy.  Dis Colon Rectum. 2009;  52(1) 4-10
    CrossrefPubMedGoogle Scholar
  • 48 Watanabe K, Funayama Y, Fukushima K, Shibata C, Takahashi K, Sasaki I. Hand-assisted laparoscopic vs. open subtotal colectomy for severe ulcerative colitis.  Dis Colon Rectum. 2009;  52(4) 640-645
    CrossrefPubMedGoogle Scholar
  • 49 Marceau C, Alves A, Ouaissi M, Bouhnik Y, Valleur P, Panis Y. Laparoscopic subtotal colectomy for acute or severe colitis complicating inflammatory bowel disease: a case-matched study in 88 patients.  Surgery. 2007;  141(5) 640-644
    CrossrefPubMedGoogle Scholar
  • 50 Fowkes L, Krishna K, Menon A, Greenslade G L, Dixon A R. Laparoscopic emergency and elective surgery for ulcerative colitis.  Colorectal Dis. 2008;  10(4) 373-378
    CrossrefPubMedGoogle Scholar
  • 51 Binder S C, Miller H H, Deterling Jr R A. Emergency and urgent operations for ulcerative colitis. The procedure of choice.  Arch Surg. 1975;  110(3) 284-289
    PubMedGoogle Scholar
  • 52 Harms B A, Myers G A, Rosenfeld D J, Starling J R. Management of fulminant ulcerative colitis by primary restorative proctocolectomy.  Dis Colon Rectum. 1994;  37(10) 971-978
    CrossrefPubMedGoogle Scholar
  • 53 Heyvaert G, Penninckx F, Filez L, Aerts R, Kerremans R, Rutgeerts P. Restorative proctocolectomy in elective and emergency cases of ulcerative colitis.  Int J Colorectal Dis. 1994;  9(2) 73-76
    CrossrefPubMedGoogle Scholar
  • 54 Ziv Y, Fazio V W, Church J M, Milsom J W, Schroeder T K. Safety of urgent restorative proctocolectomy with ileal pouch-anal anastomosis for fulminant colitis.  Dis Colon Rectum. 1995;  38(4) 345-349
    CrossrefPubMedGoogle Scholar

Scott A StrongM.D. 

Department of Colorectal Surgery, Cleveland Clinic

9500 Euclid Ave., Cleveland, OH 44195

Email: strongs@ccf.org